Author(s): Rydn L, Waeber B, Ruilope LM, Mancia G, Volpe M,
Abstract Share this page
Abstract Patients with comorbid hypertension and type 2 diabetes are common, have a greatly increased risk of premature cardiovascular and renal morbidity and mortality, and are likely to increase substantially in number over the next 10-15 years. We suggest the need for more aggressive management strategies for these patients, regardless of their baseline blood pressure, including the early use of combination therapy with blockers of the renin-angiotensin system.
This article was published in Blood Press
and referenced in Journal of Diabetes & Metabolism